RETAGLIPTIN HYDROCHLORIDE
UNII 7F70K4065S

Substance Identification & Data

This profile provides standardized clinical and technical data for Retagliptin Hydrochloride, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 7F70K4065S.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1174038-86-8 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
7F70K4065S
CAS Registry Number
1174038-86-8
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
RETAGLIPTIN HYDROCHLORIDE
Official standardized name for this substance within the FDA UNII nomenclature system.
InChIKey
C19H18F6N4O3.ClH
International Chemical Identifier digital signature for unique molecular identification.
SMILES String
DIUZSRUIUOLMSO-HNCPQSOCSA-N
Line notation for describing the chemical structure and connectivity of atoms.
NCI Thesaurus
National Cancer Institute reference terminology for clinical and research data.
PubChem CID
Unique identification number in the NCBI database of chemical substances.
Substance Type
chemical
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).
Ingredient Role
c1c(c(cc(C[C@H](CC(N2Cc3n(c(nc3C(OC)=O)C(F)(F)F)CC2)=O)N)c1F)F)F.Cl

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Retagliptin Hydrochloride. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

Common Names & Synonyms

RETAGLIPTIN HYDROCHLORIDE

Systematic Nomenclature

IMIDAZO(1,5-A)PYRAZINE-1-CARBOXYLIC ACID, 7-((3R)-3-AMINO-1-OXO-4-(2,4,5-TRIFLUOROPHENYL)BUTYL)-5,6,7,8-TETRAHYDRO-3-(TRIFLUOROMETHYL)-, METHYL ESTER, HYDROCHLORIDE (1:1)